Cargando…
N-terminal pro-brain natriuretic peptide measurements in hemodynamically significant patent ductus arteriosus in preterm infants
OBJECTIVES: Evaluate the role of NT-proBNP levels in Preterm neonates suffering from PDA and used as a screening tool for predicting HsPDA and guiding physicians to consider early echocardiographic evaluation. METHODS: This is a monocentric prospective blind study which was conducted at Arar Central...
Autor principal: | Alenazi, Shehab Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928402/ https://www.ncbi.nlm.nih.gov/pubmed/27375693 http://dx.doi.org/10.12669/pjms.323.9690 |
Ejemplares similares
-
Usefulness of Serum Brain Natriuretic Peptide Level for Screening Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates
por: Jameii Khosroshahi, Ahmad, et al.
Publicado: (2014) -
Controversy in the diagnosis and treatment of hemodynamically significant patent ductus arteriosus in preterm infants
por: Sung, Se In
Publicado: (2019) -
B-Type Natriuretic Peptide Assay for the Diagnosis and Prognosis of Patent Ductus Arteriosus in Preterm Infants
por: Kim, Joon Sik, et al.
Publicado: (2012) -
When to Treat Hemodynamically Insignificant Patent Ductus Arteriosus in Preterm Infants
por: Al-Abdi, Sameer Y.
Publicado: (2012) -
B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants
por: Mine, Kenji, et al.
Publicado: (2013)